David Lawrence is Chief & Bus. Ops & PAO at ACORDA THERAPEUTICS INC (ACOR). They have made 13 open-market trades across 1 company since 2006, most recently 2020-12-01.
CIK 0001272353
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 13 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ACOR | 13,811 | $9K |
Shares reported on the most recent Form 4, priced at the 2020-12-03 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ACOR | SELL · 10b5-1 | 2019-12-02 | 2019-12-04 | $1.60 | $2K | -7.7% | +24.0% | -32.8% |
| ACOR | SELL | 2019-02-22 | 2019-02-25 | $13.18 | $10K | +3.3% | -2.8% | -27.0% |
| ACOR | SELL | 2018-12-03 | 2018-12-06 | $20.55 | $102K | -15.8% | -12.6% | -26.9% |
| ACOR | SELL | 2018-06-12 | 2018-06-13 | $31.70 | $208K | -9.4% | -6.4% | -39.6% |
| ACOR | SELL | 2018-06-07 | 2018-06-11 | $28.12 | $1.3M | -8.0% | -9.4% | -36.0% |
| ACOR | SELL | 2018-01-18 | 2018-01-22 | $27.58 | $1.7M | -3.8% | -4.4% | -14.5% |
| ACOR | SELL | 2017-12-01 | 2017-12-05 | $20.51 | $164K | +3.2% | +3.2% | +27.2% |
| ACOR | SELL · 10b5-1 | 2017-10-09 | 2017-10-11 | $25.40 | $6K | +2.1% | +9.0% | -9.4% |
| ACOR | SELL | 2017-02-09 | 2017-02-13 | $22.32 | $2.8M | +5.3% | +18.8% | -33.8% |
| ACOR | SELL | 2016-12-01 | 2016-12-05 | $20.74 | $183K | +0.7% | -3.5% | +27.8% |
| ACOR | SELL · 10b5-1 | 2016-10-07 | 2016-10-11 | $20.82 | $5K | +2.3% | +4.9% | +8.5% |
| ACOR | SELL · 10b5-1 | 2016-06-22 | 2016-06-24 | $25.09 | $13K | +2.7% | +4.3% | +9.0% |
| ACOR | SELL · 10b5-1 | 2015-12-18 | 2015-12-22 | $40.63 | $1.6M | -8.7% | -10.6% | -38.2% |
| ACOR | SELL · 10b5-1 | 2015-12-01 | 2015-12-03 | $38.08 | $273K | -8.7% | +0.7% | -15.3% |
| ACOR | SELL · 10b5-1 | 2015-10-07 | 2015-10-09 | $29.82 | $7K | -8.7% | +0.7% | -2.3% |
| ACOR | SELL · 10b5-1 | 2014-12-18 | 2014-12-22 | $40.11 | $1.1M | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2014-12-01 | 2014-12-03 | $35.60 | $317K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2014-10-07 | 2014-10-09 | $33.60 | $8K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2013-12-02 | 2013-12-04 | $33.51 | $363K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2012-12-03 | 2012-12-05 | $24.21 | $225K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2011-12-01 | 2011-12-05 | $22.92 | $227K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2010-12-01 | 2010-12-03 | $26.54 | $289K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL | 2010-03-10 | 2010-03-12 | $34.16 | $410K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2010-02-02 | 2010-02-03 | $30.00 | $150K | -8.7% | +0.7% | +0.7% |
| ACOR | SELL · 10b5-1 | 2010-01-22 | 2010-01-26 | $28.00 | $140K | -8.7% | +0.7% | +0.7% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.